Cotización LYSOGENE
Acciones
LYS
FR0013233475
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 52 | 01/01/09 | |
Director of Finance/CFO | - | 01/01/20 | |
Marie Trad
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Peter Lichtlen
BRD | Director/Board Member | 56 | 01/04/18 |
Michel Picot
BRD | Director/Board Member | 72 | - |
Chief Executive Officer | 52 | 01/01/09 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-6,65 % | 12,54 mil M | |
+82,29 % | 4139,33 M | |
-14,23 % | 2335,16 M | |
-23,73 % | 2510,93 M | |
-19,45 % | 1663,5 M | |
+32,37 % | 1147,09 M | |
+7,42 % | 840 M | |
-11,75 % | 548 M | |
-34,49 % | 466 M |